Troya Therapeutics ApS — Credit Rating and Financial Key Figures

Troya Therapeutics ApS (CVR number: 44032589) is a company from KØBENHAVN. The company recorded a gross profit of -2381.6 kDKK in 2025. The operating profit was -5356.4 kDKK, while net earnings were -4638.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -48.4 %, which can be considered poor and Return on Equity (ROE) was -66.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -39.2 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Troya Therapeutics ApS's liquidity measured by quick ratio was 41.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.